Endocyte prices IPO stock
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
Initial Public Offerings
Articles
GM shares jump in return to Wall Street
General Motors' return to Wall Street was well received Thursday, as the company’s stock closed up 3.6 percent in its initial public offering.
Vera Bradley shares off to impressive start
Stock in the Fort Wayne-based company began trading Thursday morning at $16 but climbed as high as $23.90.
Vera Bradley set to go public
The Fort Wayne-based company is scheduled to begin trading as a public company Wednesday morning. The estimated offering price is $14 to $16 each, although a Morningstar analyst predicts the IPO could bring as much as $18 a share.
Endocyte’s $86M IPO plan a boon for Indiana, investors
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
Cancer drug developer Endocyte files for IPO
The company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet
to be determined.
Vera Bradley files for $175M IPO
The 28-year-old company reported profit in its latest fiscal year of $43.2 million on $288.9 million in sales.
EDITORIAL: Lots of promising local firms in IPO pipeline
There’s a reason we’re thrilled to see the Indianapolis area is building a healthy pipeline
of firms primed to go public: It bodes well for our economy.
Private companies struggle to raise funds once reaching critical mass
Several Indiana companies are in a position, or soon will be, to launch an initial public offering. But don’t expect a wave
of new Indiana public companies. In the recession, with both revenue and profits down, companies may choose to wait until
they have better numbers to report.
Rapid growth makes Aprimo candidate for another try at IPO
Robust growth at marketing software maker Aprimo is fueling speculation it is about to make another run at going public, and
co-founder Bill Godfrey said he won’t rule out the possibility of an IPO.
UPDATE: KAR Auction IPO raises less than hoped
The Carmel-based auctioneer had expected to raise $340.9 million through its IPO, but the company said it would sell 25 million common shares at $12 each for total proceeds of $300 million.
Australian owner abandons efforts to sell Chase Tower
Macquarie Office Trust of Sydney has quietly pulled the 48-story Chase Tower off the market, along with a property in Boston and a property in Denver that failed to draw juicy enough offers.
Green light for local IPOs?
If nothing else, you have to admire the patience shown by ExactTarget and Aprimo, two of the area’s hottest tech companies,
as they await better conditions to launch their initial public offerings.
Omnicity seeks financial turnaround, has 28 acquisitions in mind
Dick Beltzhoover, a private investor in Omnicity Corp., a Carmel-based wireless broadband provider, has quietly taken the
company public and has lofty plans to expand nationwide.